My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


Coinbase Q3 Highlights: Mixed Earnings, Predi...
SanDisk Posts Q1 Double Beat, Announces Stock...
YouTube's Living-Room Business Just Made More...
Reddit Q3 Highlights: Revenue Up 53%, but Gui...
Starbucks Stock Climbs Ahead of Earnings: Wha...
Palantir Stock Drops: What's Going On?
Oracle Stock Slides: What's Going On?
eBay Stock Nears 52-Week High on 2027 Growth...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    VIR BIOTECHNOLOGY INC (NASDAQ: VIR)

    Overview
    current price
    $11.75
    $11.75
    change
    0.00 | 0.00%
    0.00 | 0.00%
    Yesterday's Close
    11.75
    open
    0.00
    volume
    0.00 M
    30d. avg volume.
    2.04 M
    1 day
    0.00 - 0.00
    52 weeks
    4.82 - 12.00
    p/e
    0.00
    beta
    1.5943
    market cap
    1.99 B
    dividend yield
    0.00%
    Industry
    -
    VIR by TradingView
    News and Commentary
    Regeneron is Working on New Antibody Therapy for Omicron, Rival Therapies Show Mixed Results Against... Following lackluster data on the effectiveness of its COVID antibody therapy against the high mutated Omicron variant, Regeneron
    Market Update: Dow Reaches New Record Close on Verizon and Chevron Gains Stocks ended Wednesday's session mixed, with the Dow Jones rising to another record close while the S&P 500 and Nasdaq slipped lower. The S&P 500 had pared losses in late afterno...
    Market Update: Stocks May be Rallying Too Soon, United States Braces for Tough Week Ahead Investors on Wall Street lead a stock market rally on Monday on the back of weekend data that shows that social distancing measures in the U.S. may be working to slow the spread...
    IPO Update: Pharmaceuticals Stumble into the Market Two of the three recently priced public companies have fallen below their share prices, demonstrating fears of the IPO market not being very friendly since the downfall of WeWork...
    StockTwits
    StockTwits
    Most Shared
    Moderna Stock Hits New 52-Week High: What's Happening?
    Robinhood to Let Traders Buy Stocks on Weekends: 'The Market Never Sleeps'
    Anthropic Tightens Claude Rules on AI-Powered Influence Campaigns, Weapons and Surveillance
    Most Popular
    Highest Yielding Hyperscaler Bonds in October 2026: SpaceX Joins Oracle Above 7.5%
    Nancy Pelosi Discloses New $1 Million Transaction, But This Time It's Not a Stock
    Surging 700% in 2026, SanDisk Takes Center Stage in Global NAND Storage Squeeze
    popular tags
    Earnings
    Apple
    Amazon
    Coronavirus
    Tesla
    Coronavirus Impact
    Google
    China
    Microsoft
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2026 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?